Loading
Latest filing published 24 Mar 2026 for RenovoRx, Inc..
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Laurence Marton appears in our data through filings on RenovoRx, Inc. shares, published by SEC (Form 4). In total, 5 filings cover trades dated from 3 November 2022 to 20 March 2026.
Purchases make up the whole of the open-market record (3 purchases, €9,306). The amount is not disclosed for 2 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 option exercises. In 2026 alone, the filings show 1 purchase and no sales.
1 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 24 March 2026, reports an open-market purchase in RenovoRx, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations